ALPS ADVISORS INC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 113 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 3.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$111,000
-3.5%
94,343
-7.6%
0.00%0.0%
Q2 2022$115,000
-78.2%
102,065
-42.2%
0.00%
-83.3%
Q1 2022$528,000
+0.8%
176,448
-10.8%
0.01%0.0%
Q4 2021$524,000
+1.4%
197,904
-8.1%
0.01%
-25.0%
Q3 2020$517,000
+22.8%
215,434
-6.3%
0.01%
+33.3%
Q2 2020$421,000
-11.4%
229,964
-24.5%
0.01%
-14.3%
Q1 2020$475,000
-34.8%
304,725
-10.4%
0.01%
+16.7%
Q4 2019$728,000
+16.5%
340,255
+1.8%
0.01%
+20.0%
Q3 2019$625,000
-31.5%
334,246
-4.5%
0.01%
-28.6%
Q2 2019$913,000
+341.1%
349,950
+251.5%
0.01%
+250.0%
Q1 2016$207,000
-41.4%
99,558
-14.6%
0.00%
-33.3%
Q4 2015$353,000
-89.7%
116,619
-15.8%
0.00%
-25.0%
Q3 2015$3,422,000
+1117.8%
138,531
+58.3%
0.00%
+100.0%
Q2 2015$281,000
+80.1%
87,490
+100.3%
0.00%
+100.0%
Q1 2015$156,00043,6740.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders